Related News
Apr 14, 2026
Elon Musk's COVID Vaccine Comments Spark Viral Debate
After Elon Musk shared his personal experience of flu-like symptoms post COVID-19 booster, social media erupted with claims questioning vaccine safety. In parallel, unverified reports from Germany alleging 20,000-60,000 vaccine-related deaths have added fuel to the fire. Experts debunk these claims, emphasizing the role of vaccines in reducing severe COVID-19 cases and the lack of evidence for mass harm. Join us as we dissect the impact of these viral narratives and what experts are saying in response.
Apr 14, 2026
EPA's Chemical Panel Candidate List Features Controversial Return of Industry Ties
The EPA is shaking things up by seeking candidates for its Science Advisory Committee on Chemicals, crucial for guiding chemical risk evaluations. Among the 29 candidates is Michael Dourson, a figure from Trump's era known for minimizing chemical risks, alongside experts from Tesla and NASA. This selection raises eyebrows about the impacts of industry influence on public health policies.
Apr 13, 2026
Elon Musk's Bold Move: Why DOGE is the New Frontier for Legal Showdowns
Elon Musk is at the center of legal storms, wielding the Department of Government Efficiency (DOGE) to challenge several lawsuits involving his companies. Musk's strategy focuses on dodging deposition-related questions, aiming to pause or dismiss cases challenging the executive functions linked to his roles in Tesla, SpaceX, and more. Critics label it as a leverage of unconstitutional power, while supporters see it as a fight against frivolous legal hurdles. Courts have been mixed, leading to an unprecedented legal landscape.